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Three common protein isoforms of apolipoprotein E (apoE), encoded by the e2, e3, and e4 alleles of the APOE
gene, differ in their association with cardiovascular and Alzheimer’s disease risk. To gain a better understanding
of the genetic variation underlying this important polymorphism, we identified sequence haplotype variation in 5.5
kb of genomic DNA encompassing the whole of the APOE locus and adjoining flanking regions in 96 individuals
from four populations: blacks from Jackson, MS ( chromosomes), Mayans from Campeche, Mexiconp 48
( ), Finns from North Karelia, Finland ( ), and non-Hispanic whites from Rochester, MN ( ).np 48 np 48 np 48
In the region sequenced, 23 sites varied (21 single nucleotide polymorphisms, or SNPs, 1 diallelic indel, and 1
multiallelic indel). The 22 diallelic sites defined 31 distinct haplotypes in the sample. The estimate of nucleotide
diversity (site-specific heterozygosity) for the locus was . Sequence analysis of the chimpanzee0.0005 0.0003
APOE gene showed that it was most closely related to human e4-type haplotypes, differing from the human consensus
sequence at 67 synonymous (54 substitutions and 13 indels) and 9 nonsynonymous fixed positions. The evolutionary
history of allelic divergence within humans was inferred from the pattern of haplotype relationships. This analysis
suggests that haplotypes defining the e3 and e2 alleles are derived from the ancestral e4s and that the e3 group of
haplotypes have increased in frequency, relative to e4s, in the past 200,000 years. Substantial heterogeneity exists
within all three classes of sequence haplotypes, and there are important interpopulation differences in the sequence
variation underlying the protein isoforms that may be relevant to interpreting conflicting reports of phenotypic
associations with variation in the common protein isoforms.
Introduction
Apolipoprotein E (apoE) (MIM 107741) is a plasma
protein that plays a prominent role in lipid metabolism
and cholesterol transport in human tissues (Davignon et
al. 1988; Mahley and Huang 1999). In humans, apoE
is polymorphic (Utermann et al. 1977). Three common
isoforms of the protein are found in most populations:
apoE2, apoE3, and apoE4, determined at the DNA level
by the e2, e3, and e4 alleles of the APOE gene on chro-
mosome 19 (Weisgraber 1994). The alleles differ from
one another by two nonsynonymous nucleotide poly-
morphisms causing amino acid substitutions at positions
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112 and 158 of the protein (E2 is distinguished from E3
by cysrarg at 158, and E3 from E4 by cysrarg at 112)
(Rall et al. 1982). The isoforms aremetabolically distinct
and differ in their affinity for lipoprotein particles, as
well as in the extent to which they bind to apoE and
low-density lipoprotein receptors (Hui et al. 1984).
The relative frequencies of the three common alleles
have been investigated in a wide range of human pop-
ulations, and no population studied to date has lacked
polymorphism in APOE. The e3 allele is the most com-
mon allele in all populations thus far investigated (de
Knijff et al. 1994; Gerdes et al. 1996b; Corbo and Scac-
chi 1999), ranging in relative frequency from 0.536 in
African Pygmies ( ) (Zekraoui et al. 1997) tonp 70
0.911 in Mayans ( ) (Kamboh 1995). The e2np 135
allele, on the other hand, is typically the least-common
allele in most populations. The relative frequency of the
e4 allele ranges from 0.052 in Sardinians ( )np 280
(Corbo et al. 1995) to 0.407 in Pygmies ( ) (Zek-np 70
raoui et al. 1997) and is significantly negatively corre-
lated with e3 allele frequencies in African, Asian, and
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Figure 1 Locations of polymorphic variants in and around the APOE gene. The genomic location of the 23 DNA variants, identified by
sequencing 5.5 kb in 96 individuals, is shown, below the exon-intron structure of the APOE gene. An asterisk (*) marks the new variant
identified in the Mayan sample from Campeche at position 3701, and x’s show the population distribution of the observed polymorphisms (J
p Jackson, C p Campeche, N p North Karelia, and R p Rochester). Variants that result in amino acid substitutions are boxed.
European populations (Corbo and Scacchi 1999). Sta-
tistically significant differences in allele frequencies,
even among closely related white populations from Eu-
rope and the United States, have long been recognized
(Davignon et al. 1988). Recently, a north-to-south de-
cline in the relative frequency of the e4 allele in Europe
(and an associated increase in e3 frequency) has been
noted by several investigators (Corbo et al. 1995; Lu-
cotte et al. 1997).
The large number of surveys of the APOE polymor-
phism reflect a long-standing interest in the relationship
of allelic variation to interindividual differences in total
serum cholesterol and LDL cholesterol levels (Sing and
Davignon 1985), effects that make the gene a key can-
didate susceptibility locus for coronary artery disease
(CAD) (Kaprio et al. 1991; Xhignesse et al. 1991). Nu-
merous studies have confirmed that within a given pop-
ulation, individuals carrying at least one e2 allele have
higher levels of circulating apoE, lower levels of plasma
total cholesterol, and higher triglyceride levels, whereas
individuals with an e4 allele have lower apoE levels,
higher total cholesterol levels, and, accordingly, a higher
risk of developing CAD (Davignon et al. 1988; de Knijff
et al. 1994; Stenga˚rd et al. 1995). More recently, allelic
variation at the APOE locus also has been associated
with both familial and sporadic cases of Alzheimer dis-
ease (AD) (MIM 104300). It is now recognized that
inheritance of e4 alleles increases the risk of AD in a
dose-dependent manner and predisposes carriers to an
earlier age at onset than matched controls (Corder et
al. 1993; Strittmatter et al. 1993). In relative terms,
possession of an e2 allele appears to protect carriers
against the disease (Chartier-Harlin et al. 1994; Corder
et al. 1994; Talbot et al. 1994). The ease with which
such relationships may be described, however, belies the
considerable context-dependence of the inferred asso-
ciations. For example, the extent to which APOE var-
iation predicts cholesterol level varies with genetic back-
ground, age, gender, and other environmental factors
(diet, smoking, etc.) (Reilly et al. 1992; Davignon 1993).
There are also ethnic differences in AD risk (see Tang
et al. 1996, 1998; Sahota et al. 1997).
Somewhat surprisingly, the epidemiological focus has
been almost exclusively on the classic isoforms; allelic
heterogeneity in the APOE gene has been only incom-
pletely characterized. The observation of enhanced lev-
els of APOE mRNA in the brains and plasma of AD
patients (Yamada et al. 1995; Lambert et al. 1997; Tad-
dei et al. 1997) has led recently to the investigation of
DNA-sequence variation in theAPOE promoter region,
resulting in the identification of five new polymorphic
sites upstream of the gene (Artiga et al. 1998b; Lambert
et al. 1998a). Single-site association studies focused on
these variants, as well as on a site found at position
113 (Mui et al. 1996), have come to contradictory
conclusions however, so that, to date, no clear consensus
exists regarding the extent to which these sites may or
may not be relevant to disease risk. Although the in-
creasingly complex picture of APOE biological varia-
tion suggested by conflicting reports is sobering, it is
important to recognize that even these many variants
do not encompass the full extent of APOE variation
present at the DNA-sequence level. In the first system-
atic resequencing study of the whole of the APOE locus
and associated 5′ and 3′ flanking DNA, we recently iden-
tified 22 variable sites, 14 of which had not been pre-
viously reported (Nickerson et al., in press). The rela-
tionship of this newly identified sequence variation to
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the three common isoforms which have formed the basis
of most epidemiological inquiry to date is the focus of
this report.
Ultimately, the fundamental question dogging both
the epidemiological and population-genetics literature
is why different apoE isoforms exist at all, with gen-
erally similar frequencies around the world, particularly
when nonhuman primate relatives show no such vari-
ation (Zannis et al. 1985). Several investigators have
suggested that e4 is the ancestral form of the gene (Hix-
son et al. 1988; Hanlon and Rubinsztein 1995; Seixas
et al. 1999). If this is so, then the high relative frequency
of the derived e3 allele in all human populations clearly
demands explanation. Has the e3 allele drifted to its
current frequency by chance, or is it selectively main-
tained? Have the amino acid differences that determine
the e3 isoform arisen once, or is there evidence that they
have recurred multiple times? These questions can be
addressed by consideration of the evolutionary history
of APOE, recorded in the arrangement of polymorphic
sites linked as DNA-sequence haplotypes. When vari-
ation is considered in this way, we can assess how and
when the three common alleles arose and can determine
what forces may have contributed to their current global
distribution. We have undertaken such an analysis here.
We show that there is considerable sequence hetero-
geneity among the haplotypes in each class of common
allele (e2, e3, and e4) and that the history of allelic
divergence suggested by the observed haplotype varia-
tion is consistent with a global expansion of e3 alleles,
relative to the ancestral e4 alleles. Detailed considera-
tion of the heterogeneity underlying each of the com-
mon alleles also provides important new insights into
the population-specific distribution of subclasses of al-
leles, which may go some way toward explaining re-
ported discrepancies in the association between varia-
tion in risk of disease and variation in the gene marked
by the common apoE isoforms.
Material and Methods
Populations Sampled
Individuals from four populations were sampled for
sequence variation: blacks from Jackson, Mississippi
( chromosomes), recruited as part of an ongoingnp 48
study of hypertension in American blacks (see Family
Blood Pressure Program Web site); whites from North
Karelia, Finland ( ), collected as part of the Finrisknp 48
Hemostasis Study (Salomaa et al. 1994); whites from
Rochester, MN ( ) from the Rochester Familynp 48
Heart Study (Turner et al. 1989); andMayans, with little
external admixture ( ), sampled by one of usnp 48
(K.M.W.) in the state of Campeche on the Yucatan Pen-
insula of Mexico (Kidd et al. 1991). All subjects were
selected for this survey without regard to their disease
status or their levels of any risk-factor trait.
DNA Sequencing
DNA sequencing was done on templates prepared by
PCR from diploid genomic DNA samples following pro-
cedures described in Nickerson et al. (in press). Extensive
confirmatory resequencing was also done on a subset of
the samples to aid haplotype determination, as described
below.
Human and chimpanzee are sufficiently similar in
DNA sequence at this locus for us to use the same array
of PCR and sequencing primers for the chimpanzee-se-
quence analysis (exact details of the primers used are
available on request). DNA from a single chimpanzee
(Pan troglodytes) was sequenced as described above and
was aligned to the human genomic consensus sequence,
using the SIM sequence-alignment algorithm (Huang et
al. 1990). The Genbank accession number for the chim-
panzee APOE reference sequence is AF261280.
Haplotype Determination
Haplotypes were determined by a sequential proce-
dure involving application of an algorithm that first
identifies unambiguous haplotypes in homozygotes and
single-site heterozygotes and then follows a series of in-
ferential steps to arrive at a call of likely haplotypes
(Clark 1990). To simplify inference, we began by ig-
noring six singleton polymorphisms (i.e., sites in which
only a single copy of the less-common nucleotide variant
was present in the combined sample—namely, 308, 545,
2907, 3106, 3673, and 3701), and a multiallelic indel
polymorphism at site 5229B. Key pairs of sites were then
identified for allele-specific PCR to assign phasing of a
subset of multiply heterozygous individuals. This phase
information then was incorporated into the inferential
procedure, until all genotypes were resolved (see Clark
et al. 1998). Allele-specific PCR was also done, to assign
phase for every genotype that could have been composed
of more than one pair of haplotypes that were unam-
biguously present in the sample. The phasings of the
singleton variants were subsequently inferred either by
context (e.g., the singletons at sites 545 and 3701 oc-
curred in homozygous backgrounds and thus were un-
ambiguously assigned) or by reference to haplotypes in-
ferred in a larger survey of variation at the same locus
(Nickerson et al., in press and unpublished data).
Population Genetic Analysis
Two measures of diversity were computed for each of
the four population samples and the combined (pooled)
sample: v, an estimate of the expected per-site nucleotide
heterozygosity, theoretically equal to the neutral muta-
tion parameter 4Nem (Watterson 1975) and p, the direct
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estimate of per-site heterozygosity derived from the av-
erage pairwise sequence difference (Nei 1987). The test
statistic D (Tajima 1989) was used to compare these
summary statistics. Under neutrality, the two estimates
should be equal and . Two test statistics—relatedDp 0
to Tajima’s D, F, and DFL (Fu and Li 1993)—were used
to compare the observed number of singleton polymor-
phisms in each sample with those expected under a neu-
tral model (we used the form of the test statistics that
explicitly incorporates outgroup information). Finally, a
fourth test statistic, Fs (Fu 1997), was used to compare
the observed number of sequence haplotypes in our sam-
ples to the number expected under the assumption of an
infinite-sites (IS) model of mutation with no recombi-
nation. Again, under neutrality (and if no recombination
is acting), the two estimates are expected to be equal.
Significance values for each of the four test statisticswere
computed by comparison to a distribution of estimates,
calculated for 1,000 random samples of the same size
and level of polymorphism as the observed data and
generated under a Wright-Fisher equilibrium model of
the coalescent, with no recombination (Hudson 1990).
Heterogeneity in theD, F, andDFL test statistics across
the length of the 5.5-kb sequenced region was examined
by use of the sliding window feature of the program
DnaSP v. 3.0 (Rozas and Rozas 1999). Statistics were
calculated for overlapping windows of 750 bp, placed
at 25-bp intervals along the sequence. Sequence diver-
gence between the chimpanzee outgroup sequence and
the human polymorphic sample was measured as K, the
net sequence divergence (Nei 1987). Sliding-window es-
timation of p and K (using the same window and step
size as in the test-statistic analyses) allowed considera-
tion of cross-locus heterogeneity in the ratio of poly-
morphism to divergence. Pairwise linkage disequilibrium
was measured with the linkage disequilibriumparameter
D, calculated as , where is the frequencyDp P  p p Pij i j ij
of the most common gametic type for a pair of sites,
and and are the frequencies of the nucleotides inp pi j
that haplotype (Hartl and Clark 1997). The genetic dif-
ferentiation among population samples was measured
with the statistic (Wright 1931), which measures theFST
fraction of the total genetic variation that is between,
rather than within, populations, estimated with the pro-
gram Arlequin.
The mutational relationships among the inferred se-
quence haplotypes, which reflect the evolutionary his-
tory of genetic changes at the APOE locus, were visu-
alized by means of the Reduced Median (RM) Network
algorithm (Bandelt et al. 1995). The RM algorithm un-
ambiguously links haplotypes that differ by a single var-
iable site and then employs a frequency-based compat-
ibility criterion to choose among equally likely
mutational paths linking remaining haplotypes. In other
words, the algorithm assumes that mutational events
typically proceed from a more frequent haplotype to a
less frequent one (a statistical assumption that is sup-
ported by coalescent theory). Although this assumption
can be violated if selection is acting, for a data set such
as the one described here—in which a large number of
closely related haplotypes are compared—the assump-
tion is rarely required; thus, it is unlikely this assumption
biases the final result. In cases where apparent parallel-
isms cannot be resolved, the uncertainty is depicted as
a reticulation, or loop, in the network. Haplotypes are
represented in each network by open circles, and the
area of each circle is proportional to the number of cop-
ies of that haplotype in the sample. RM networks were
constructed for the combined total sample and each of
the four population samples using the RM option of the
program Network 2.0 by A. Ro¨hl.
Maximum-likelihood (ML) estimates of the neutral
mutation parameter v were derived for the IS-compatible
data only, following the approach of Griffiths and Ta-
vare´ (1997). Sites that exhibit homoplasies cannot be
considered in this analysis, which also assumes station-
ary populations and selectively neutral variation. Esti-
mates of diversity for the IS-compatible samples were in
no case significantly different from those estimated for
the original data, suggesting that no major biases were
introduced by data truncation. The analysis was per-
formed with the combined sample, as well as each of
the individual population samples. The assumption of
constant population size was tested explicitly by com-
paring likelihood estimates for models with and without
population expansion. No significant improvement in
likelihood was observed when exponential populational
growth was included in the model, when either the com-
bined sample or separate population samples were con-
sidered. Therefore, all calculations were performed as-
suming constant population size. Associated age
estimates, for both the time to the most recent common
ancestor (TMRCA) and individual mutations, were gen-
erated in units of 2Ne generations and converted to years
using the estimate of effective population size derived
from the ML estimate of v ( ) and an estimated4Nem
generation time of 20 years. The latter conversion as-
sumed a mutation rate, m, of /locus/gener-41.29# 10
ation, calculated under the assumption of a human-
chimp divergence of 5 million years before present (BP)
(Horai et al. 1992), as described previously by Harris
and Hey (1999). This estimate is calculated from the net
number of sequence differences observed between hu-
man and chimpanzee (64.7), an estimate which ignores
length variation/divergence and does not take functional
constraint into account. The reported uncertainty in the
age estimates also does not take uncertainty in the es-
timates of either and m into account. Although theNe
simplifications preclude precision, the approach provides
a general characterization of the evolutionary history of
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a gene. All calculations were carried out with the pro-
gram Genetree (Griffiths and Tavare´ 1997).
Results
APOE Diversity at the Nucleotide Level
The nature, amount, and population distribution of
nucleotide polymorphism identified at the APOE locus
in three of the four populations investigated here is de-
scribed in the report by Nickerson et al. (in press). In
summary, 22 variable sites were identified in the 5,491-
bp region surveyed: 21 diallelic single-nucleotide poly-
morphisms (SNPs) and one multiallelic insertion/dele-
tion polymorphism (at 5229A, figure 1 and table 1). Five
sites were singletons; that is, only a single copy of the
rarer allele was observed in the sample of 144 chro-
mosomes (i.e., sites 308, 545, 2907, 3106, and 3673;
site 3106 is a nonsynonymous substitution), whereas
another five “doubleton” sites had two copies of the
rarer nucleotide (sites 73, 471, 1522, 1575, and 4036;
site 4036 is a nonsynonymous substitution). In this
study, APOE sequence variation in a fourth population,
from the state of Campeche, Mexico, was also surveyed,
bringing the total number of chromosomes investigated
for sequence diversity to 192. One new, singleton inser-
tion variant was identified in the Campeche sample, at
position 3701 of the reference sequence (involving an
insertion of CT dinucleotide) (fig. 1 and table 1). An
additional eight polymorphic sites were present in the
Campeche sample, all of which had been identified in
the earlier investigation (560, 832, 1163, 1998, 2440,
3937, 4075, and 5229B). None of the previously iden-
tified singleton or doubleton variant alleles were ob-
served in the new sample. The positions of all 23 vari-
ants, relative to the reference sequence reported by
Nickerson et al. (in press), are shown in figure 1.
Summary statistics describing the sequence diversity
in the combined sample, and each of the four population
samples, are presented in table 2. Overall, average per-
nucleotide expected heterozygosity (v) for the total sam-
ple, estimated from the observed number of polymorphic
sites (Watterson 1975), was . An equiv-0.0007 0.0002
alent estimate, based on the average pairwise sequence
difference p (Nei 1987), was slightly lower (0.0005
). These estimates are lower than, but not sig-0.0003
nificantly different from, estimates of diversity reported
for other autosomal (Li and Sadler 1991; Harding et al.
1997; Clark et al. 1998; Rana et al. 1999; Rieder et al.
1999; Hamblin and Di Rienzo 2000) and X-linked (Ziet-
kiewicz et al. 1998; Harris and Hey 1999; Jaruzelska et
al. 1999; Kaessmann et al. 1999) human genetic loci.
Estimated values of Tajima’s (1989) D and Fu and Li’s
(1993) and F statistics did not differ significantlyDFL
from 0. More than the expected number of haplotypes
were observed in all four population samples, as well as
the combined sample and this excess haplotype varia-
tion, as measured by the Fs statistic (Fu 1997), was
highly significant in both the Jackson and combined
samples. The observed excess haplotype diversity is
likely to reflect the effects of recurrent mutation and/or
interallelic recombination, as discussed below.
Haplotype Variation Underlying the Common APOE
Alleles
The 22 variants observed in the total sample of 192
chromosomes were found to segregate as 31 distinct se-
quence haplotypes (the phase of the multiallelic indel at
site 5229Awas not determined). These haplotypes, num-
bered in order of descending relative frequency in the
combined sample, aligned with respect to overall se-
quence similarity, and arranged according to the classical
protein-allele that their variation at positions 3937 and
4075 defines (i.e., e2, e3, e4), are shown in table 1. We
observed no examples of the fourth configuration of iso-
form-determining cSNPs in our sample (i.e., the hap-
lotype combination C-T at sites 3937 and 4075, as op-
posed to T-T [e2], T-C [e3], or C-C [e4]). The failure to
observe the C-T haplotype in our sample is consistent
with previous surveys of apoE polymorphism, which
have never observed that combination of amino acid
substitutions (de Knijff et al. 1994).
In the combined sample, 13 (0.068) of the observed
sequence haplotypes comprise e2 alleles, 152 (0.792) are
e3 alleles, and 27 (0.140) are e4 alleles (table 1). The
relative proportions of the three alleles vary among pop-
ulation samples, however, with the greatest relative fre-
quency differences associated with e2-type sequence hap-
lotypes (table 1). This latter class of sequence haplotype
was not observed at all in the Campeche sample, for
example (relative frequencies of e2, e3, and e4 were 0,
0.896, and 0.104, respectively), and is much more com-
mon in the Rochester sample (relative frequencies 0.188,
0.687, and 0.125) than in either of the other two pop-
ulation samples (relative frequencies in the Jackson sam-
ple were 0.042, 0.854, and 0.104, and those in theNorth
Karelia sample were 0.042, 0.729, and 0.229). Marked
interpopulation differences in the relative frequency of
the e2 allele ( , ) are consistent with2x p 8.29 Pp .004
previous observations (Corbo and Scacchi 1999).
Full sequence analysis and haplotype determination
reveal substantial heterogeneity within each of the three
protein allelic classes (table 1). The rarest allelic class,
e2, is comprised of five distinct sequence haplotypes in
the total sample, with variation at four nucleotide sites
(table 1). Similarly, the most common allelic class, e3,
comprises 17 distinct sequence haplotypes, which vary
at 14 sites. Finally, nine different e4-type haplotypeswere
observed, which vary at 10 positions. One half of the
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Table 2
Diversity Estimates and Neutrality Tests for APOE
RESULTS FOR POPULATION SAMPLES
Jackson Campeche North Karelia Rochester Pooled Sample
na 48 48 48 48 192
Sb 14 8 13 13 22
sc 4 2 2 1 6
v (# 104)d 5.75  2.17 3.28  1.44 5.33  2.05 5.33  2.05 6.87  2.05
p (# 104)e 4.36  2.41 3.92  2.21 5.62  2.97 6.37  3.30 5.31  2.80
D (Tajima 1989) .736 .531 .163 .586 .619
DFL(Fu and Li 1993) .438 .148 .506 1.05 1.09
F (Fu and Li 1993) .650 .090 .464 1.07 1.09
No. of haplotypes 16 9 13 18 31
Expected no. of haplotypesf 7.8  2.2 7.3  2.1 9.1  2.4 9.8  2.5 12.9  3.1
Fs (Fu 1997) 7.080*** .963 2.378 6.203* 15.055***
a Number of chromosomes surveyed.
b Number of polymorphic sites, excluding site 5229A indel.
c Number of singleton sites.
d Expected heterozygosity per nucleotide, SEs derived from variance estimate assuming no recombination
(Watterson 1975).
e Average pairwise sequence difference, SEs derived from stochastic and sampling variance, assuming no re-
combination (Nei 1987).
f Mean  SD of estimates derived from distribution of 1,000 random samples (see Material and Methods).
* .P ! .05
*** .P ! .001
polymorphic sites found in either the e2 or the e3 group
of haplotypes occur as singletons in those groups, and
five of the six singletons found in the combined sample
are linked to e3-type sequence haplotypes. In contrast,
only 2 of the 10 sites segregating within the e4 group
occur as singletons. The large number of variable sites
found among the comparatively less common e4 class
of haplotypes results in an estimate of v for this group
of alleles that is the same as that observed for the e3s
( in both cases). e2-type haplotypes are0.0005 0.0002
less internally polymorphic by the same measure (vp
).0.0002 0.0001
Comparison of the homologous genomic region in
chimpanzee (Pan troglodytes) identified 76 fixed se-
quence differences between the human consensus (Gen-
bank accession AF261279) and chimpanzee (GB
AF261280) sequences, including 63 nucleotide substi-
tutions and 13 length differences ranging from 1 to 36
bp in length. The associated estimate of net sequence
divergence between human and chimpanzee, which takes
into account human polymorphic variation (Nei 1987),
was 64.7 (calculation of this estimate ignored length
variation/divergence). For every diallelic nucleotidepoly-
morphism observed in humans, one of the two alleles
was present at the homologous position in chimpanzee
(table 1). In all but one case (site 3937), the more com-
mon human variant corresponded to the presumed an-
cestral allele. Although the chimpanzee haplotype se-
quenced here cannot be considered as representative of
all APOE variation in that species, the nucleotide ob-
served at this position in chimpanzee (C) is also present
in other nonhuman primate species (Hanlon and Rub-
insztein 1995), suggesting that it is, in fact, the true an-
cestral state at this position. Haplotype 12, one of the
e4 haplotypes, has the same configuration of nucleotides
at the 22 variable positions as is observed at homologous
sequence positions in chimpanzee, but this haplotype
still differs from that of the chimpanzee at 75 additional
positions. This observation is consistent with previous
analyses, which have suggested that the e4 allele is the
ancestral APOE allele on the basis either of sequence
comparisons with nonhuman primates (Hixson et al.
1988; Hanlon and Rubinsztein 1995) or of patterns of
linkage disequilibrium between APOE and the down-
stream locus APOCI (Seixas et al. 1999).
Evolutionary History of APOE Allelic Divergence
The likely genealogical history of the observed vari-
ation was inferred from RM networks (Bandelt et al.
1995) constructed for haplotypes in the combined sam-
ple (fig. 2) and each of the separate population samples
(fig. 3). In a RM network, circles correspond to indi-
vidually distinct haplotypes (as presented in table 1),
with the size of the circles scaled to reflect the relative
frequency of each haplotype in the sample. The haplo-
types are connected to one another by branches, along
which mutational differences are indicated. For example,
in figure 2, haplotypes 5 and 18 differ from one another
by mutational changes at sites 4951 and 5361, whereas
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Figure 2 RM network of APOE sequence haplotypes in the
pooled total sample. Mutational relationships are indicated by lines
linking the 31 unique haplotypes, indicated in the network as circles
(lighter lines indicate inferred mutational relationships that are less
likely if homoplasy caused by recombination or recurrent mutation
involving site 560 is assumed). The size of each circle is proportional
to the relative frequency of the haplotype in the total sample. Muta-
tional differences between haplotypes are indicated on the branches
of the network (variants and haplotypes are numbered as in table 1;
mutations that result in amino acid substitutions are boxed). Haplo-
type 12 (shaded) is the root haplotype in the network. The three large
boxes indicate the groups of haplotypes that define the e2, e3, and e4
APOE alleles.
Figure 3 RM networks of APOE haplotypes in the four pop-
ulation samples. Networks describing haplotype relationships, as they
are found in each individual sample, are shown in black. Other
branches, which are present in the total network but missing in a
particular sample, are indicated in light gray. Numbers label haplo-
types only (mutations are not indicated). Boxes indicate groups of
haplotypes that define the e2, e3, and e4 alleles, as presented in figure
2.
haplotypes 5 and 15 differ by a change at site 624 only.
When the connections among the haplotypes are traced,
the history of mutational changes at the locus can be
inferred, particularly if outgroup information allows
identification of the “root” haplotype in the network
(haplotype 12, as noted above).
As shown in the RM network for the total sample
(fig. 2), the 31 APOE haplotypes fall into four major
lineages, or clades, which correspond coherently to the
protein allelic classes defined by variation at sites 3937
and 4075, consistent with the arrangement depicted in
table 1. The e2 and e4 groups of haplotypes each com-
prise phylogenetically distinct lineages. The e3 group of
haplotypes, however, is comprised of two discrete,
equally frequent clades, separated by three mutational
steps (involving changes at sites 832, 1163, and 2440)
and two transitional haplotypes (6 and 19), suggesting
a significant bifurcation in the lineage undetected by pre-
vious surveys of either protein-level or DNA-level var-
iation. A third minor subclade, leading to haplotypes 8
and 27, also extends from the core haplotype (6) in this
group.
The root haplotype in the network is haplotype 12,
which encodes an apoE4 isoform. Only two copies of
this haplotype are present in the total sample, one copy
in Jackson and one in Rochester (table 1). The presence
of the root in the sample from Jackson is consistent with
other studies of human genetic variation, which have
found root haplotypes in black African populations (e.g.,
Harding et al. 1997; Harris and Hey 1999). The RM
network shows clearly that the predominant e3 allelic
class is derived from the e4 group by a single-step change
from the root haplotype, involving site 3937, the cSNP
that causes the cysrarg substitution at residue 112 of
the apoE protein. e2-type haplotypes are derived from
the core haplotype of the e3 group by two changes, one
at site 5229B and one at the previously recognized cSNP
at site 4075. Apart from the core e3 haplotype (haplo-
type 6), all other haplotypes in the combined sample are
two mutational steps from the root haplotype.
Homoplasy of Upstream Regulatory-Region Variants
A prominent feature of the data illustrated in the RM
network is the homoplasy (the inferred occurrence ofmul-
tiple independent evolutionary events giving rise to the
same allelic state at a variable site) that affects sites in
and around the APOE locus. In all, 7 of the 22 variants
in the phased haplotypes show some evidence of homo-
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Table 3
APOE Site Heterozygosity and Observed Homoplasy versus Potential Mutability
Sitea Heterozygosity Homoplasyb Repeat Motif Mutability Typec Surrounding Sequenced
73 .02 1 MIR 3 AGGATTCACGcCCTGGCAATT
308 .01 1 0 CCACCCCTCCcATCCCACTTC
471 .02 1 AluSq 0 CCAAGTAGCTaGGATTACAGG
545 .01 1 AluSq 0 ACCATGTTGGcCAGGCTGGTC
560 .35 8 AluSq 0 CTGGTCTCAAaCTCCTGACCT
624 .13 6 AluSq 0 AGGCGTGAGCtACCGCCCCCA
832 .50 2 0 AGGGTGTCTGgATTACTGGGC
1163 .46 1 0 ACCCTGGGAAgCCCTGGCCTC
1522 .02 1 3 TGAGGTTGGAgCTTAGAATGT
1575 .02 2 1 GAGATGGAACcGGCGGTGGGG
1998 .19 2 0 CCCCATTCAGgCAGACCCTGG
2440 .46 1 0 CTGGCTGGGAgTTAGAGGTTT
2907 .01 1 3 CTGCCCACCAtGGCTCCAAAG
3106 .01 1 0 CGCTGGGAACtGGCACTGGGT
3673 .01 1 0 GCCTCTGCCCcGTTCCTTCTC
3701 .01 1 0 TGGTCTCTCT^GGCTCATCCC
3937 .24 1 1 GGAGGACGTGcGCGGCCGCCT
4036 .02 1 1 GCGCAAGCTGcGTAAGCGGCT
4075 .13 1 1 CCTGCAGAAGcGCCTGGCAGT
4951 .04 3 AluSg 0 AGTAGAGACGaGCTTTCACCA
5229Ae .63 … AluJo 2 TGGGGGGGGG^GTGGTGTGTG
5229B .13 1 AluJo 2 TGGGGGGGGGgTGGTGTGTGT
5361 .12 3 2 CCCAGCTTTTtATTATTATTT
a Location of polymorphic site relative to reference sequence, as presented in Nickerson et al. (in press).
b Homoplasy p homoplasy count, i.e. number of independent mutations that must be invoked to explain
observed haplotype diversity in the combined sample.
c Type 0 p no known mutational motif; type 1 p CpG; type 2 p mononucleotide run; type 3 p alpha
polymerase arrest site (Templeton et al. 2000).
d ^ p location of polymorphic indel.
e Multiallelic indel (haplotype phase undetermined), all other sites are diallelic SNPs or indels.
plasy, and two sites in particular, 560 and 624 (corre-
sponding, respectively, to the regulatory region variants
at 491 and 427 reported previously by Artiga et al.
1998b) occur repeatedly in the RM network. Two un-
resolved loops and a double loop broken by an assump-
tion of recurrent mutation at site 560, all suggest multiple
mutational and/or short recombinational events at those
sites. Site 560 (491) is particularly homoplasic, occur-
ring eight separate times in the network of the combined
sample (between haplotypes 1 and 4, 1 and 26, 12 and
13, 6 and 8, 2 and 3, 20 and 23, 10 and 16, and 9 and
22 in fig. 2). In fact, homoplasy at site 560 was so pro-
nounced that confirmatory allele-specific amplifications
on 1100 individuals were done to ensure that the site had
been correctly phased. Site 624 (427) occurs six times
in the network. Other homoplasic sites include 4951 and
5361, in the 3′ flanking region (with three occurrences
each), and sites 832 (219), 1575, and 1998 (with two
occurrences each) (table 3). The inferred homoplasy is not
restricted to any particular class of allele: occurrences of
the same mutational state at different places in the net-
work are associated with e2-, e3-, and e4-type haplotypes.
This observation is consistent with previous reports,
which have suggested that the association of variation at
these sites with AD risk is often independent of e4 allelic
status (Artiga et al. 1998a; Bullido et al. 1998).
The observed homoplasy, which is consistent with the
excess haplotype diversity suggested by the Fs test sta-
tistic, can be explained as arising either from recurrent
mutation, or as a consequence of interhaplotype recom-
bination (either reciprocal exchange or gene conversion).
Reciprocal recombination would be expected to lead, at
least some of the time, to exchanges of multiple adjacent
sites, like those described in a recent investigation of
variation at the LPL locus (Templeton et al. 2000), but
these are not observed. Also, unlike in LPL (Clark et al.
1998), only a small proportion of site pairs show all
four gametic types (38, or 16.5%, of 231 comparisons
in the combined sample) (table 4), suggesting that the
data are dominated more by extreme homoplasy in a
few sites than extensive recombination across the whole
of the sequenced region. That homoplasy affects sites
located at the 5′ and 3′ ends of the sequenced region is
consistent with the inferred lack of reciprocal exchange
events, and yet, as noted earlier, no instances of the T-
C cSNP haplotype involving sites 3937 and 4075 were
observed.
Although nearly half of the variable positions iden-
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Table 4
Significant Pairwise Linkage Disequilibria (D) and Four-Gamete Site Pair Counts
Jackson Campeche North Karelia Rochester Pooled Sample
Da for Sample
Site 1/Site 2:
73/4036 .040*** .010***
624/4075 .078** .032***
624/5229B .078** .032***
832/1163 .140*** .195*** .153*** .199*** .187***
832/1998 .039 .084** .047* .051***
832/2440 .119*** .130*** .214*** .146*** .167***
832/3937 .018 .039 .084** .029 .045***
832/4075 .010 .023 .082** .031***
832/5229B .010 .023 .082** .031***
1163/1998 .054* .076** .030 .037***
1163/2440 .109*** .109*** .132*** .118*** .129***
1163/3937 .022 .054* .076** .044 .050***
1998/3937 .093*** .156*** .073*** .084***
2440/3937 .054* .022 .091** .042 .051***
4075/5229B .040*** .040*** .152*** .063***
Data Summary for Sample
Total no. of pairwise LD comparisons 45 15 55 66 120
No. significant at P! .001 5 4 5 5 15
Proportion 11.1% 26.7% 9.1% 7.6% 12.5%
Total no. of pairwise four-gamete comparisons 91 28 78 78 231
No. with four gametes 9 3 17 25 38
Proportion 9.9% 10.7% 21.8% 32.0% 16.5%
a Disequilibrium statistics are reported as , where is the frequency of the most common gametic typeDp P  pp Pij i j ij
for a pair of sites, and are the frequencies of the nucleotides in that haplotype. Tail probability is reported for Fisher’sp pi j
Exact Test.
* ..01 ! P ! .05
** ..001 ! P ! .01
*** .P ! .001
tified at APOE arise at known mutational hotspot mo-
tifs, only two of the seven homoplasic sites (sites 1575
and 5361) occur in such regions (table 3). This would
argue against recurrent mutation as generating the in-
ferred homoplasy. The two most homoplasic sites, sites
560 and 624, fall in the midst of an Alu repeat sequence,
as does the moderately homoplasic site 4951 (table 3).
The level of sequence polymorphism associated with
such repetitive sequences in the 5.5 kb surveyed is not
higher than that observed in nonrepeat regions (Nick-
erson et al., in press) so the significance, if any, of these
associations is unclear. In the absence of direct empirical
evidence, it is impossible to decide whether gene con-
version or recurrent mutation is a more plausible ex-
planation of the observed patterns. Interestingly, al-
though the two sites that define the e2-e3-e4 poly-
morphism (3937 and 4075) both fall in CpG dinucleo-
tides (that are known to be methylated inAPOE [Larsen
et al. 1993] and thus, in principle, are likely to be hot-
spots of mutation [Cooper and Krawczak 1989]), the
RM network does not suggest homoplasy at these sites.
The high degree of site homoplasy, combined with the
large number of low frequency variants, explains the
comparatively low level of linkage disequilibrium (LD)
observed among site pairs at the APOE locus within
each of the sampled populations. Five or fewer site pairs
in each population sample were found with a significant
level of LD (Fisher’s exact test ) and only 15P ! .001
pairs (12.5% of all pairwise comparisons) were signif-
icant at this level in the pooled sample (table 4). Site
832 was in significant LD with the largest number of
sites in the combined sample (1163, 1998, 2440, 3937,
4075, and 5229B). However, only associations between
site 832 and sites 1163 and 2440 were consistently ob-
served across separate population samples. It is also im-
portant to note that, whereas 7 of the 15 significant site
pairs in the combined sample involve the commonly-
typed cSNPs at sites 3937 and 4075, only two pairs
involving these sites (1998-3937 and 4075-5229B) show
consistent associations in the separate population sam-
ples (table 4). The pattern of LD observed in this small
sample is generally similar to LD estimated from a much
larger sample of unphased genotype data for the same
sites (Nickerson et al., in press and unpublished data).
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Table 5
Pairwise Estimates of Population Subdivision (FST)
Jackson Campeche North Karelia Rochester
Jackson …
Campeche .127*** …
North Karelia .068** .035* …
Rochester .052*** .054*** .034* …
* (by haplotype-based permutation).P ! .05
** (by haplotype-based permutation).P ! .01
*** (by haplotype-based permutation).P ! .001
More precise understanding of the LD pattern in APOE
awaits detailed haplotype-based analysis of that larger
sample.
Population Differences in APOE Diversity
Sequence haplotype diversity, as it is found in the sep-
arate samples, suggests small but significant differences
in the genetic make-up of the four populations surveyed.
The overall estimate of (Weir 1996) for the combinedFST
sample was calculated as 0.060 ( , by haplotypeP ! .001
permutation). Pairwise estimates of (table 5) rangedFST
from a high of 0.127 between samples from Jackson and
Campeche ( ) to a low of 0.034 between Roch-P ! .001
ester and North Karelia ( ). These estimates areP ! .05
comparable to those calculated from an average of site-
specific estimates, where an overall FST value of 0.045
was observed (Nickerson et al., in press). The higher
degree of differentiation of the populations at the hap-
lotype level is consistent with the population-specific dis-
tribution of haplotypes: 18 (0.581) of the 31 haplotypes
identified occur in single population samples (table 1),
whereas 11 (0.478) of the 23 variable sites are restricted
to one sample only (Nickerson et al., in press) (table 1).
The greatest proportion of unique haplotypes (7 of 18,
or 0.389) was found in the Rochester sample. Six hap-
lotypes were shared by two samples only, two haplotypes
by three samples, and five haplotypes (1, 2, 3, 4, and 7)
by all four population samples (table 1). Haplotype 5
(which belongs to the e4 group of sequence haplotypes)
is missing from the Jackson sample, despite the fact that
it is found at a higher overall relative frequency than
haplotype 7 in the combined sample.
Differences in the population-distribution of the ob-
served haplotypes are clearly illustrated by the sample-
specific RM networks presented in figure 3. Most ap-
parent is the absence of the e2 clade of sequence
haplotypes in the Mayan sample from Campeche, an
observation consistent with the low overall level of se-
quence diversity in that sample (table 2), as well as pre-
vious reports of apoE polymorphism, which have noted
the absence of e2 alleles in other New World population
samples (Crews et al. 1993; Kamboh 1995; Scacchi et
al. 1997). The extent of e2 haplotype variation found
in the other three samples also differs: e2s are represented
by pairs of singleton haplotypes in the Jackson and
North Karelia samples, whereas the full repertoire of e2
variation is present in the sample from Rochester. Pop-
ulation differences in the distribution of e3 haplotypes
are less striking. The two most common types of e3s
(haplotypes 1 and 2) are observed in all four samples,
as are the closely associated derivative haplotypes, 3, 4,
and 7. The core e3 haplotype (haplotype 6) is, however,
absent in the European samples (North Karelia and
Rochester) and the rare haplotype 19, which links hap-
lotype 6 to haplotype 1, is observed only in the black
sample from Jackson. The remaining interpopulation
differences in the distribution of e3 haplotypes largely
involve rare variants, which differ from the common e3
haplotypes by one or, at most, two sites. Homoplasy at
sites 560 and 624, which results in the unresolved loops
in the e2 and e3 clades of the total RM network (fig. 2),
is observed in the Rochester sample only (fig. 3).
The most important difference among the population
sample networks involves the composition of the e4
clade in the four samples. The two subbranches of the
e4 group observed in the sample from Jackson (leading
to haplotypes 17 and 20) are completely absent in the
other three population samples, whereas the portion of
the e4 clade observed in the Mayan and European-de-
rived population samples (dominated by haplotype 5, as
noted above) is missing in the sample from Jackson. The
degree to which these branches are present in all pop-
ulations—but at low frequency and, hence, not captured
in samples of 48 chromosomes from each popula-
tion—remains to be seen from other and/or larger sam-
ples. In any case, the observed sample differences suggest
an ethnic and/or geographic difference in the relative
frequency of e4 subtypes, which clearly merits further
investigation in the context of conflicting risk associa-
tions in the literature. The nucleotide polymorphism that
distinguishes haplotype 5 from the Jackson-specific e4s
is site 1998, a previously unrecognized variant that falls
at the 5′ end of intron 2 (fig. 1).
Time Depth of APOE Variation
RM networks summarize the mutational relationships
among sequence haplotypes but provide no indication
of the time period over which the sequence differences
have arisen. Determination of the time depth of the e2-
e3-e4 APOE polymorphism is relevant both to under-
standing the current geographic distribution of the pro-
tein-level polymorphism and to assessing the relative
impact of demographic and selective processes on the
observed variation. The most straightforward way to
estimate the time depth of polymorphism is to compare
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Figure 4 Scaled coalescent gene tree of IS-compatible APOE
variation in the total (pooled) sample. The tree shows the inferred
genealogical history of the 16 haplotypes compatible with the IS model
(indicated by the numbered labels marking each terminal branch at
the bottom of the tree; haplotype numbering as in table 1). The mean
estimated ages of variants in the tree, indicated as numbered points
within the genealogy, were derived by the program Genetree. For
branches with multiple mutations, the order of mutations in time is
arbitrary. Horizontal lines are drawn underneath the groups of hap-
lotypes that define the e2, e3, and e4 APOE alleles, respectively. Mu-
tations that result in amino acid substitutions are boxed.
Table 6
Estimates of Population Genetic Parameters from Genetree
Sample na Sb vW
c vML
d Ne
e TMRCA
f (#105 years)
Agef of Site 3937
(#105 years)
Average Agef
of Other Sites
(#105 years)
Jackson 48 12 2.7 3.23 6,260 2.92 (1.59–5.40) 2.09 (1.08–4.13) .54
Campeche 48 6 1.35 1.32 2,558 1.99 (.95–4.03) 1.44 (.68–3.10) .46
North Karelia 46 10 2.28 2.44 4,729 2.73 (1.49–5.03) 2.0 (1.04–3.92) .63
Rochester 46 10 2.28 2.5 4,845 2.7 (1.45–5.04) 2.06 (1.04–4.03) .56
Pooled 183 18 3.11 3.66 7,093 3.11 (1.76–5.79) 2.2 (1.22–4.40) .45
a Sample size after removal of non–IS-compatible data (details of sites and haplotypes excluded available on
request).
b Number of IS-compatible polymorphic sites.
c Watterson (1975) estimator of v per locus, based on S.
d ML estimate of v, per locus, from Genetree program (see Material and Methods).
e Effective population size, derived from vML and assuming /locus/generation.
4mp 1.29# 10
f Median age estimates, derived assuming the given Ne and a generation time of 20 years. In parentheses, 2.5%
and 97.5% points of the age distribution are given.
the observed level of intraspecific diversity within hu-
mans to the number of fixed interspecific differences ob-
served between humans and chimpanzees. As noted
above, the net sequence divergence between human and
chimp APOE genes was estimated as 64.7; the average
pairwise sequence difference among human haplotypes
in the same genomic region was 2.93. If a constant mo-
lecular clock is assumed and the humans-chimpanzee
time of divergence is taken as 5 million years BP (Horai
et al. 1992), the time required to generate the observed
variation would be ∼226,000 years.
To get a fuller picture of the timing of APOE allelic
divergence, we also analyzed the variation using an ML
method based on a coalescent model of neutral sequence
evolution (Griffiths and Tavare´ 1997), which uses all of
the information in a haplotype network to infer the
TMRCA of the observed variation, as well as ages of in-
dividual mutations (for indicative previous analyses us-
ing the same methodology, see Harding et al. [1997] and
Harris and Hey [1999]). Estimates of the total time
depth of APOE variation and specific mutational ages
were calculated for the combined sample and each of
the separate population samples (table 6). One gene tree,
depicting the evolutionary relationships among haplo-
types in the combined sample and summarizing age es-
timates for mutations in that tree, is shown in figure 4.
The main features of this tree are found in each of the
trees generated for the separate population samples, al-
though the overall time depth of the variation (sum-
marized by the TMRCA estimates in table 6) varies, due
to differences in the haplotype composition of the re-
spective samples.
There are three main features of interest. First, the
estimate of the TMRCA (i.e., the total time-depth of the
tree) is 311,000 years BP (with a 95% credibility interval
ranging from 176,000 to 579,000 years BP). Estimates
are of the order of 200,000–300,000 years BP, when
variation in the separate population samples is consid-
ered (table 6). This time depth is lower than, but not
significantly different from, an equivalently derived es-
timate of years for the TMRCA of hu-770,000 420,000
man b-globin diversity, the time depth of which is
roughly that expected of a neutral autosomal locus (Har-
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ding et al. 1997). Second, site 3937, the cSNP that dis-
tinguishes e2 and e3 alleles from e4 alleles, is the oldest
mutation in the tree and is approximately twice as an-
cient as any of the other mutations in the IS-compatible
data set (fig. 4). The age of site 3937 suggested by the
ML analysis ranges from 150,000–220,000 years BP
(table 6). Finally, all of the other mutations in the tree
are estimated to have arisen within the past 90,000
years, and several within the past 10,000 years. The
average age of all sites other than site 3937 is ∼50,000
years in each of the population samples examined (table
6). Even if we could have incorporated all homoplasic
sites in this analysis (as described in the Material and
Methods section, these were excluded in order to con-
form to the requirement for an IS-compatible data set),
this striking difference in the relative age of site 3937,
which reflects the high relative frequency of the derived
allele at this site in our sample, would have remained.
A key assumption underlying these analyses is that the
variation is selectively neutral. If this assumption is met,
then these analyses suggest that the divergence between
e4 and the e2 and e3 clades (dated by the mutation at
site 3937) began ∼200,000 years ago and that most of
the subsequent intraallelic divergence has occurred only
comparatively recently in human history, within the past
60,000 years. If, instead, selection has acted to increase
the relative frequency of the mutation at site 3937 (as
discussed below), then the inferred ages may overesti-
mate the antiquity of the e2-e3-e4 polymorphism, be-
cause sites in the sample would then be at a higher rel-
ative frequency than expected, given the influence of
random genetic drift alone. In either case, the recent
origin of the APOE protein polymorphism suggested by
these age estimates is not consistent with the long-stand-
ing maintenance of the e2, e3, and e4 alleles in human
populations as a balanced polymorphism.
Evidence for Departure from Selective Neutrality
Of the four test statistics estimated from patterns of
variation found in the whole 5.5-kb sequenced region
surveyed, three (D, , and F) suggested no statisticallyDFL
significant deviation from selective neutrality (table 2).
Although the fourth, Fs, did suggest departures from
neutral expectation for the Jackson, Rochester, and com-
bined samples, as discussed earlier, the extensive site ho-
moplasy in these samples suggests that this deviation is
more likely explained by the effects of interhaplotype
recombination than genetic hitchhiking. In addition,
HKA test (Hudson et al. 1987) comparisons of levels of
APOE polymorphism and divergence to that observed
at two other equivalently sampled human autosomal
genes, LPL (Clark et al. 1998; Nickerson et al. 1998)
and b-globin (Harding et al. 1997), suggested no sig-
nificant differences ( , data not shown). By all ofP 1 .05
these standard general measures, then, APOE sequence
variation indicates a remarkably good fit to neutral
expectation.
Nevertheless, several features of the data appear
broadly consistent with the selective expansion of the
e3-type sequence haplotypes defined by site 3937. As
noted earlier, five of the six singleton variants in the
combined sample are linked to e3-type sequence hap-
lotypes. Low frequency variation is expected to accom-
pany the rise in frequency of an advantageous mutant,
as preexisting variation in a population is replaced in
the “sweep” to fixation of the haplotype containing the
advantageous site (Fu and Li 1993). The size of the ge-
nomic region affected depends on the strength of selec-
tion and the recombination rate; if the recombination
rate is high, the region of sequence affected by the sweep
will be small, and only sites in the immediate genomic
vicinity of the selected site will show the expected fre-
quency disturbance (Kaplan et al. 1989). In this context,
it is relevant that the singleton variants in our sample
all fall immediately upstream of the fourth exon, where
the mutation at site 3937 is located (fig. 1). Sliding win-
dow estimates of the F test statistic (which measures the
extent to which polymorphism is characterized by excess
singleton variation), suggests a consistent excess of low
frequency variation in the center of the sequenced region,
encompassing bases 3000–4500 (fig. 5). Moreover, al-
though the 1 kb of sequence that lies upstream of exon
4 is characterized by a low level of polymorphism (mea-
sured as average pairwise sequence difference p), inter-
specific sequence divergence (measured by net sequence
divergence, K) in this central segment is higher than in
adjoining regions, reflecting a marked discordance be-
tween patterns of polymorphism and divergence in this
portion of the sequenced region (fig. 6). This difference
is consistent with the recent loss of variation in a region
with a normal-to-high underlying rate of neutral
mutation.
Discussion
The global ubiquity of the three common apoE isoforms
and, in particular, the persistently high relative frequency
of the e3 allele in all human populations, has puzzled
investigators and prompted much speculation regarding
the evolutionary forces responsible for the observed poly-
morphism (e.g., Hanlon and Rubinsztein 1995; Corbo
and Scacchi 1999; Finch and Sapolsky 1999). As has been
recognized in the population-genetics literature for many
years, however, it is nearly impossible to distinguish
among competing explanations when variation at the
amino acid level alone is considered (Lewontin 1985). It
is only when the nucleotide-level diversity underlying pro-
tein polymorphism is considered that relevant inferences
can be made (see, e.g., Kreitman 1983).
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Figure 5 Sliding-window analysis of the F test statistic (Fu and Li 1993). Estimates of F were calculated for overlapping 750-bp-wide
windows placed at 25-bp steps along the 5.5-kb sequenced region. The value for each window was plotted at the midpoint of the window and
these points were linked by a continuous line for ease of inspection. Sliding window plots for the pooled sample and each of the separate
population samples are shown (J p Jackson, C p Campeche, N p North Karelia, R p Rochester). The location of the APOE exons within
the sequenced region are shown directly beneath the plot for the combined sample.
When we look beneath the surface of apoE protein
polymorphism, we discover something unexpected. Al-
though considerable, previously unrecognized variation
underlies the three common isoforms, the observed het-
erogeneity is far less than would be expected if the three
alleles had persisted for a long time in human populations
as a balanced polymorphism.Despite thewidespreadma-
jor polymorphism at the amino acid level, the APOE
locus remains one of the less variable genes that has been
examined by in-depth resequencing. With an average nu-
cleotide diversity (p) of 0.0005, APOE is less variable
than LPL ( ) (Clark et al. 1998; Nickerson etpp 0.002
al. 1998), ACE ( ) (Rieder et al. 1999), b-pp 0.0009
globin ( ) (Harding et al. 1997) or MC1Rpp 0.002
( ) (Rana et al. 1999; Harding et al. 2000). Thepp 0.002
low level of variation is not a function of a low neutral
mutation rate: the mutation rate estimated here,
/locus/generation, is of the same order of41.29# 10
magnitude as estimates for many other human nuclear
loci (Harding et al. 1997; Clark et al. 1998; Zietkiewicz
et al. 1998; Harris and Hey 1999; Jaruzelska et al. 1999).
Nor is the low level of sequence diversity consistent with
expected effects of balancing selection, whose influence
would serve to allow greater variation to accumulate in
the regions flanking the target of selection as a conse-
quence of genetic hitchhiking. Instead, the observed poly-
morphism is more consistent with a reduction in varia-
tion associated with the rise in frequency of an
advantageous mutation (i.e., the amino acid–altering T
allele at 3937), which, in the process of increasing in
frequency toward fixation, has “swept” away linked
variation.
However, none of the test statistics applied to the ob-
served variation suggest anything other than a good fit
to the expectations of selective neutrality. The failure to
reject neutrality with these tests is likely to reflect the
narrowwindow of the sequence affected by the suggested
perturbations, the relatively low level of polymorphism
in our sample, and the fact that the null distributions of
the statistics are generated under the assumption of a
conservative model in which no recombination is acting
(Wall 1999). Even given the peculiarities of the data set
analyzed here, these test statistics are notorious for their
lack of power (see, e.g., Simonsen et al. 1995), and at
least one author has argued that this lack of power may
stem directly from inappropriateness of the equilibrium
neutral model normally assumed (Gillespie 2000). What
is clear is that these (and related) test statistics have failed
to indicate departures from neutrality for at least two
other human loci for which there is compelling, inde-
pendent evidence of selective effects, namely b-globin
(Harding et al. 1997) and the Duffy blood group locus
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Figure 6 Sliding-window analysis of APOE polymorphism (p) and interspecific divergence (K). Estimates of average pairwise sequence
difference, p, among the human haplotypes and net sequence divergence, K, between the haplotypes and the chimpanzee APOE sequence, were
calculated for overlapping 750-bp-wide windows placed at 25-bp steps along the 5.5-kb sequenced region. p is plotted as a light line (and with
respect to the scale on the left) and K is plotted in bold (and with respect to the scale on the right). The location of the APOE exons within
the sequenced region are shown beneath the plot.
(Hamblin and Di Rienzo 2000). Therefore, although we
did not find statistically significant evidence of the effects
of natural selection on APOE variation, it is not unrea-
sonable to infer that selection has acted. The value of
examining this possibility closely is heightened by the
variety of phenotypes with which the protein isoforms
have been associated.
Precisely when the new variant at site 3937, and its
associated haplotypes, began to expand in frequency rel-
ative to the ancestral allele is uncertain and is unlikely
to be resolved using analytical methods that assume se-
lective neutrality (such as those employed here). The pres-
ence of both e3 sublineages in each of the four popula-
tions investigated, in the absence of evidence for recurrent
mutation at the sites involved, is consistent with site 3937
having arisen prior to the major population expansions
that accompanied the spread of anatomically modern
humans !100,000 years ago. Alternatively, strong selec-
tive pressure may have facilitated the global distribution
of the variant much more recently. Indirect evidence in
support of the latter hypothesis is the fact that the basal
haplotype of the e3 clade (haplotype 6) is absent in the
European samples from Rochester and North Karelia
(hence, if present, likely to be at low frequency in those
populations), suggesting that the rise in frequency of the
e3s in Europe may have occurred after the differentiation
of the clade into two primary lineages. The low overall
level of population heterogeneity (FST p 0.06) is also
consistent with a recent rapid expansion of e3. In either
case, the lower relative frequency and patchy geograph-
ical distribution of the e2 haplotypes, as well as their
clear derivation from the e3 clade, suggest that the variant
defining these latter alleles (at site 4075) arose
subsequently.
A relevant question is whether known phenotypic ef-
fects associated with the observed variation contribute to
current differences in reproductive fitness. There is strong
evidence that the inheritance of an e4 allele places carriers
at a higher risk of succumbing to CAD or AD, at least
in European and Asian populations (Davignon et al.
1988; Roses 1996). The deleteriousness of e4, relative to
that of e3, is consistent with the history of long-term
genetic change at the APOE locus, but CAD and AD are
both diseases of late adulthood or old age, and increased
susceptibility to these conditions would not be expected
to result in important differences in reproductive success
(for an opposing argument, see Finch and Sapolsky
[1999]). The widely expressed protein does play many
different roles in the body, including facilitation of lipid
absorption, neural growth and regeneration, and immune
function (Mahley and Huang 1999), one or more of
which could have a direct effect on fertility or could
contribute to differential survival and reproductive suc-
cess. One study has suggested that men carrying at least
one e3 allele have, on average, more children than men
with other APOE genotypes (Gerdes et al. 1996a). Al-
ternatively, APOE variation may reflect an adaptation to
changing diets (Hanlon and Rubinsztein 1995), such as
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those which accompanied the transition from subsistence
to agricultural economies (Corbo and Scacchi 1999),may
play a key role in neurological response to head injury
(Friedman et al. 1999), or may mediate susceptibility to
lipophylic pathogens (Martin 1999).
Population-level differences in the distribution of
APOE variation are relevant to a comprehensive predic-
tion of risk and understanding of disease etiology.Despite
the low overall level of polymorphism at theAPOE gene,
considerable heterogeneity characterizes each of the three
common alleles at the sequence level, heterogeneitywhich
helps explain previously perplexing association results.
For example, in a 5-year prospective epidemiological
study of AD incidence among different ethnic groups,
Tang et al. (1998) found that, compared to e3/e3 ho-
mozygotes, the relative risk (RR) of AD associated with
one or more copies of the e4 allele was significantly in-
creased among whites (RR 2.5) but not among blacks
(RR 1.0) or Hispanics (RR 1.1). These results confirmed
previous reports suggesting that the association of e4with
AD is weaker or nonexistent among blacks living in New
York City (Tang et al. 1996) and Indiana (Sahota et al.
1997), as well as among black Nigerians (Osuntokun et
al. 1995) and East Africans (Sayi et al. 1997). Similar
variation is found regarding lipids (Xu et al. 1999). These
observations take on new significance in the light of our
finding that geographic and/or ethnic differences exist in
the distribution of haplotypes within the e4 class (fig. 3).
If, as our results suggest, different types of e4 alleles are
found at different relative frequencies in different geo-
graphic regions, this heterogeneity (which may be related
to nonneutral forces acting on the locus) can be—indeed,
must be—accounted for.
Similarly, our data provide an invaluable evolutionary
context in which to interpret more circumscribed anal-
yses. There has, for instance, recently been much interest
in characterizing APOE promoter-region polymorphism
and examining the association of such variants with AD
and CAD risk. These analyses have met with only limited
success. Either the observed variants have turned out not
to explain any greater proportion of the observed vari-
ance in phenotype than explained by the common allelic
variants or positive associations in one population have
failed to be replicated in subsequent studies. The most
problematic discrepancies in this regard have centered on
the role of the 491 variant (Artiga et al. 1998b). Some
workers have suggested that variation at this site is a
strong determinant of AD risk (Artiga et al 1998a; Bul-
lido et al 1998), whereas other researchers have either
questioned the importance of the polymorphism relative
to other regulatory region variants (Lambert et al. 1998b;
Town et al. 1998), or failed to replicate the association
altogether (Roks et al. 1998; Song et al. 1998). Our anal-
ysis suggests a possible explanation:491 (site 560 here)
appears to be particularly susceptible to recurrent mu-
tation and/or gene conversion, placing it in association
with different allelic backgrounds, with different func-
tional effects, in different populations. In this context, it
is unsurprising that results have conflicted. On the other
hand, the prominent placement of site 832 (219) in our
inferred haplotype network, as a site defining major sub-
types of both e3 and e4 haplotypes in multiple popula-
tions, appears consistent with the association of this site
with differences in both AD risk (Lambert et al. 1998a,
1998b) and myocardial infarction (Lambert et al. 2000).
The relationship of other variants with unique positions
in the APOE gene tree (particularly sites 1163 and 2440
among e3s and site 1998 among e4s) clearly merit de-
tailed investigation. When large samples are typed at
these variable sites, and relevant phenotypes are scored,
it will be possible to test directly the independence of
effects of the variable sites on lipid phenotypes.
Our survey of DNA-sequence variation at the human
apolipoprotein E locus has been simultaneously exhaus-
tive and wholly preliminary. We have not characterized
the full extent of sequence variation as it arises at the
gene on a global scale, nor have we attempted to identify
polymorphisms in linked regions that might contribute
in important ways to gene expression and disease etiol-
ogy. Nevertheless, our investigation has done what pre-
vious studies had only approximated: a systematic in-
vestigation of sequence haplotype variation, as it occurs
in the whole of the APOE gene and its nearby flanking
regions, in samples drawn from nonclinical populations.
The analysis reveals a young polymorphism with its gen-
esis in recent human history and yet, despite this recency,
encompassing an intricate and largely unforeseen heter-
ogeneity with important implications for our understand-
ing of the biology that variation encodes. Because it has
been so extensively studied, APOE is an excellent model
gene to illustrate the importance of considering genetic
variation thoroughly (e.g.,Martin et al. 2000), preferably
without making prior assumptions about causation. It is
clear from that study as well as from our own work that
there is no consistent or specifically predictable relation-
ship among sites within a gene. In particular, convenient
or even simplistic assumptions that only coding variation
is important, or that the effect of each variable site in a
gene acts independently of the others, can be tested. The
recent discovery of regulatory sites with apparent effects
on lipid and AD risk factors demonstrates this clearly,
and this gene has more surprises of the same type in store
(C. F. Sing, unpublished data).
Acknowledgments
We thank B. P. Lazzaro and E. T. Dermitzakis for comments
on the manuscript. We are also grateful to two anonymous
reviewers for their suggestions. We acknowledge support from
Fullerton et al.: APOE Haplotype Variation 897
National Heart, Lung, and Blood Institute grants HL39107,
HL58238, HL58239, and HL58240.
Electronic-Database Information
Accession numbers and URLs for data in this article are as
follows:
Arlequin, http://lgb.unige.ch/arlequin (for Arlequin program)
DnaSP, http://www.bio.ub.es/˜julio/DnaSP.html (for DnaSP
software)
Family Blood Pressure Program Web site, http://www
.hypertensiongenetics.org
Fluxus Engineering, http://www.fluxus-engineering.com/shar-
enet.htm (for Network 2.0 software)
Genbank, http://www.ncbi.nlm.nih.gov/entrez/ (for chimpan-
zee APOE reference sequence [AF261280])
Genetree, http://www.maths.monash.edu.au/˜mbahlo/mpg/
gtree.html (for Genetree software)
Online Mendelian Inheritance in Man (OMIM), http://www
.ncbi.nlm.nih.gov/Omim (for apoE [MIM 107741] and AD
[MIM 104300])
References
Artiga MJ, Bullido MJ, Frank A, Sastre I, Recuero M, Garcia
MA, Lendon CL, Han SW, Morris JC, Vazquez J, Goate A,
Valdivieso F (1998a) Risk for Alzheimer’s disease correlates
with transcriptional activity of the APOE gene. Hum Mol
Genet 7:1887–1892
Artiga MJ, Bullido MJ, Sastre I, Recuero M, Garcia MA, Al-
dudo J, Vazquez J, Valdivieso F (1998b) Allelic polymor-
phisms in the transcriptional regulatory region of apolipo-
protein E gene. Fed Europ Bioch Soc Letters 421:105–108
Bandelt HJ, Forster P, Sykes BC, Richards MB (1995) Mito-
chondrial portraits of human populations using median net-
works. Genetics 141:743–753
Bullido MJ, Artiga MJ, Recuero M, Sastre I, Garcia MA, Al-
dudo J, Lendon C, Han SW, Morris JC, Frank A, Vazquez
J, Goate A, Valdivieso F (1998) A polymorphism in the
regulatory region of APOE associated with risk for Alzhei-
mer’s dementia. Nat Genet 18:69–71
Chartier-Harlin MC, Parfitt M, Legrain S, Perez-Tur J, Brous-
seau T, Evans A, Berr C, Vidal O, Roques P, Gourlet V,
Fruchart JC, Delacourte A, Rossor M, Amouyel P (1994)
Apolipoprotein E, epsilon 4 allele as a major risk factor for
sporadic early and late-onset forms of Alzheimer’s disease:
analysis of the 19q13.2 chromosomal region. HumMol Ge-
net 3:569–574
Clark AG (1990) Inference of haplotypes from PCR-amplified
samples of diploid populations. Mol Biol Evol 7:111–122
Clark AG, Weiss KM, Nickerson DA, Taylor SL, Buchanan
A, Stenga˚rd J, Salomaa V, Vartiainen E, Perola M, Boer-
winkle E, Sing CF (1998) Haplotype structure and popu-
lation genetic inferences from nucleotide-sequence variation
in human lipoprotein lipase. Am J Hum Genet 63:595–612
Cooper DN, Krawczak M (1989) Cytosine methylation and
the fate of CpG dinucleotides in vertebrate genomes. Hum
Genet 83:181–188
Corbo RM, Scacchi R (1999) Apolipoprotein E (APOE) allele
distribution in the world: is APOE*4 a “thrifty” allele? Ann
Hum Genet 63:301–310
Corbo RM, Scacchi R, Mureddu L, Mulas G, Alfano G (1995)
Apolipoprotein E polymorphism in Italy investigated in na-
tive plasma by a simple polyacrylamide gel isoelectric fo-
cusing technique. Comparison with frequency data of other
European populations. Ann Hum Genet 59:197–209
Corder EH, Saunders AM, Risch NJ, Strittmatter WJ, Schme-
chel DE, Gaskell PC Jr, Rimmler JB, Locke PA, Coneally
PM, Schmader KE, Small GW, Roses AD, Haines JL, Peri-
cak-Vance MA (1994) Protective effect of apolipoprotein E
type 2 allele for late onset Alzheimer disease. Nat Genet 7:
180–184
Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE,
Gaskell PC, Small GW, Roses AD, Haines JL, Pericak-Vance
MA (1993) Gene dose of apolipoprotein E type 4 allele and
the risk of Alzheimer’s disease in late onset families. Science
261:921–923
Crews DE, Kamboh MI, Mancilha-Carvalho JJ, Kottke B
(1993) Population genetics of apolipoprotein A-4, E, and H
polymorphisms in Yanomami Indians of northwestern Bra-
zil: associations with lipids, lipoproteins, and carbohydrate
metabolism. Hum Biol 65:211–24
Davignon J (1993) Apolipoprotein polymorphism and ather-
osclerosis. In: Born GVR, Schwartz CJ (eds) New horizons
in coronary heart disease. Current Science, London, pp
5.1–5.21
Davignon J, Gregg RE, Sing CF (1988) Apolipoprotein E poly-
morphism and atherosclerosis. Arteriosclerosis 8:1–21
de Knijff P, van den Maagdenberg AM, Frants RR, Havekes
LM (1994) Genetic heterogeneity of apolipoprotein E and
its influence on plasma lipid and lipoprotein levels. Hum
Mutat 4:178–194
Finch CE, Sapolsky RM (1999) The evolution of Alzheimer
disease, the reproductive schedule, and apoE isoforms. Neu-
robiol Aging 20:407–428
Friedman G, Froom P, Sazbon L, Grinblatt I, Shochina M,
Tsenter J, Babaey S, Yehuda B, Groswasser Z (1999) Apo-
lipoprotein E-e4 genotype predicts a poor outcome in sur-
vivors of traumatic brain injury. Neurology 52:244–248
Fu Y-X (1997) Statistical tests of neutrality of mutations
against population growth, hitchhiking, and background se-
lection. Genetics 147:915–925
Fu Y-X, Li W-H (1993) New statistical tests of neutrality for
DNA samples from a population. Genetics 133:693–709
Gerdes LU, Gerdes C, Hansen PS, Klausen IC, Faergeman O
(1996a) Are men carrying the apolipoprotein epsilon 4- or
epsilon 2 allele less fertile than epsilon 3/epsilon 3 geno-
types? Hum Genet 98:239–242
Gerdes LU, Gerdes C, Hansen PS, Klausen IC, Faergeman O,
Dyerberg J (1996b) The apolipoprotein E polymorphism in
Greenland Inuit in its global perspective. Hum Genet 98:
546–550
Gillespie JH (2000) Genetic drift in an infinite population: the
pseudohitchhiking model. Genetics 155:909–919
Griffiths RC, Tavare´ S (1997) Computational methods for the
coalescent. In: Progress in population genetics and human
898 Am. J. Hum. Genet. 67:881–900, 2000
evolution. Donnelly P, Tavare´ S (eds) Springer-Verlag, New
York, pp 165–182
Hamblin MT, Di Rienzo A (2000) Detection of the signature
of natural selection in humans: evidence from the Duffy
blood group locus. Am J Hum Genet 66:1669–1679
Hanlon CS, Rubinsztein DC (1995) Arginine residues at co-
dons 112 and 158 in the apolipoprotein E gene correspond
to the ancestral state in humans. Atherosclerosis 112:85–90
Harding RM, Fullerton SM, Griffiths RC, Bond J, Cox MJ,
Schneider JA, Moulin DS, Clegg JB (1997) Archaic African
and Asian lineages in the genetic ancestry of modern hu-
mans. Am J Hum Genet 60:772–789
Harding RM, Healy E, Ray AJ, Ellis NS, Flanagan N, Todd
C, Dixon C, Sajantila A, Jackson IJ, Birch-MachinMA, Rees
JL (2000) Evidence for variable selective pressures atMC1R.
Am J Hum Genet 66:1351–1361
Harris EE, Hey J (1999) X chromosome evidence for ancient
human histories. Proc Natl Acad Sci USA 96:3320–3324
Hartl DL, Clark AG (1997) Principles of population genetics.
3d ed. Sinauer Associates, Sunderland, MA
Hixson JE, Cox LA, Borenstein S (1988) The baboon apoli-
poprotein E gene: structure, expression, and linkage with
the gene for apolipoprotein C-1. Genomics 2:315–323
Horai S, Satta Y, Hayasaka K, Kondo R, Inoue T, Ishida T,
Hayashi S, Takahata N (1992) Man’s place in Hominoidea
revealed by mitochondrial DNA genealogy. J Mol Evol 35:
32–43
Huang XQ, Hardison RC, Miller W (1990) A space-efficient
algorithm for local similarities. Comput Appl Biosci 6:
373–381
Hui DY, Innerarity TL, Mahley RW (1984) Defective hepatic
lipoprotein receptor binding of B-very low density lipopor-
etins from type III hyperlipoproteinemic patients. J Biol
Chem 259:860–869
Hudson RR (1990) Gene genealogies and the coalescent pro-
cess. Oxf Surv Evol Biol 7:1–44
Hudson RR, Kreitman M, Aguade´ M (1987) A test of neutral
molecular evolution based on nucleotide data. Genetics 116:
153–159
Jaruzelska J, Zietkiewicz E, Batzer M, Cole DE, Moisan JP,
Scozzari R, Tavare´ S, Labuda D (1999) Spatial and temporal
distribution of the neutral polymorphisms in the last ZFX
intron: analysis of the haplotype structure and genealogy.
Genetics 152:1091–1101
Kaessmann H, Heissig F, von Haeseler A, Pa¨a¨bo S (1999) DNA
sequence variation in a non- coding region of low recom-
bination on the human X chromosome. Nat Genet 22:78–81
Kamboh MI (1995) Apolipoprotein E polymorphism and sus-
ceptibility to Alzheimer’s disease. Hum Biol 67:195–215
Kaplan NL, Hudson RR, Langley CH (1989) The “hitchhiking
effect” revisited. Genetics 123:887–899
Kaprio J, Ferrell RE, Kottke BA, Kamboh MI, Sing CF
(1991)Effects of polymorphisms in apolipoproteins E, A-IV,
and H on quantitative traits related to risk for cardiovas-
cular disease. Arterioscler Thromb 11:1330–1348
Kidd JR, Black FL, Weiss KM, Balazs I, Kidd KK (1991) Stud-
ies of three Amerindian populations using nuclear DNA
polymorphisms. Hum Biol 63:775–794
Kreitman M (1983) Nucleotide polymorphism at the alcohol
dehydrogenase locus of Drosophila melanogaster. Nature
304:412–417
Lambert J-C, Perez-Tur J, Dupire M-J, Galasko D, Mann D,
Amouyel P, Hardy J, Delacourte A, Chartier-Harlin MC
(1997) Distortion of allelic expression of apolipoprotein E
in Alzheimer’s disease. Hum Mol Genet 6:2151–2154
Lambert J-C, Berr C, Pasquier F, Delacourte A, Frigard B,
Cottel D, Perez-Tur J, Mouroux V, Mohr M, Cecyre D,
Galasko D, Lendon C, Poirier J, Hardy J, Mann D, Amouyel
P, Chartier-Harlin MC (1998b) Pronounced impact of Th1/
E47cs mutation compared with - 491 ATmutation on neural
APOE gene expression and risk of developing Alzheimer’s
Disease. Hum Mol Genet 7:1511–1516
Lambert J-C, Brousseau T, Defosse V, Evans A, Arveiler D,
Ruidavets J-B, Haas B, Cambou JP, Luc G, Ducimetiere P,
Cambien F, Chartier-Harlin MC, Amouyel P (2000) Inde-
pendent association of an APOE gene promoter polymor-
phism with increased risk of myocardial infarction and de-
creased APOE plasma concentrations—the ECTIM study.
Hum Mol Genet 9:57–61
Lambert J-C, Pasquier F, Cottel D, Frigard B, Amouyel P, Char-
tier-Harlin M-C (1998a) A new polymorphism in the APOE
promoter associated with risk of developing Alzheimer’s
Disease. Hum Mol Genet 7:533–540
Larsen F, Solheim J, Prydz H (1993) A methylated CpG island
3′ in the apolipoprotein-E gene does not repress its tran-
scription. Hum Mol Genet 2:775–780
Li WH, Sadler LA (1991) Low nucleotide diversity in man.
Genetics 129:513–523
Lewontin RC (1985) Population genetics. Annu Rev Genet 19:
81–102
Lucotte G, Loirat F, Hazout S (1997) Pattern of gradient of
apolipoprotein E allele *4 frequencies in western Europe.
Hum Biol 69:253–262
Mahley RW, Huang Y (1999) Apolipoprotein E: from ather-
osclerosis to Alzheimer’s disease and beyond. Curr Opin
Lipidol 10:207–217
Martin ER, Lai EH, Gilbert JR, Rogala AR, Afshari AJ, Riley
J, Finch KL, Stevens JF, Livak KJ, Slotterbeck BD, Slifer SH,
Warren LL, Conneally PM, Schmechel DE, Purvis I, Pericak-
Vance MA, Roses AD, Vance JM (2000) SNPing away at
complex diseases: analysis of single-nucleotide polymor-
phisms around APOE in Alzheimer disease. Am J Hum Ge-
net 67:383–394
Martin GM (1999) APOE alleles and lipophylic pathogens.
Neurobiol Aging 20:441–443
Mui S, Briggs M, Chung H, Wallace RB, Gomez-Isla T, Rebeck
GW, Hyman BT (1996) A newly identified polymorphism
in the apolipoprotein E enhancer gene region is associated
with Alzheimer’s disease and strongly with the e4 allele.
Neurology 47:196–201
Nei M (1987) Molecular evolutionary genetics. Columbia Uni-
versity Press, New York
Nickerson DA, Taylor SL, Weiss KM, Clark AG, Hutchinson
TG, Stenga˚rd J, Salomaa V, Vartiainen E, Boerwinkle E, Sing
CF (1998) DNA sequence diversity in a 9.7-kb region of the
human lipoprotein lipase gene.. Nat Genet 19:233–240
Nickerson DA, Taylor SL, Fullerton SM, Weiss KM, Clark
AG, Stenga˚rd J, Boerwinkle E, Sing CF. Sequence diversity
Fullerton et al.: APOE Haplotype Variation 899
and large-scale typing of SNPs in the human apolipoprotein
E gene. Genome Res (in press)
Osuntokun BO, Sahota A, Ogunniyi AO, Gureje O, Baiyewu
O, Adeyinka A, Oluwole SO, et al (1995) Lack of an as-
sociation between apolipoprotein E epsilon 4 and Alzhei-
mer’s disease in elderly Nigerians. Ann Neurol 38:463–465
Rall SC Jr, Weisgraber KH, Mahley RW (1982) Human apo-
lipoprotein E: the complete amino acid sequence. J Biol
Chem 257:4171–4178
Rana BK, Hewett-Emmett D, Jin L, Chang BH, Sambuughin
N, Lin M, Watkins S, Bamshad M, Jorde LB, Ramsay M,
Jenkins T, Li WH (1999) High polymorphism at the human
melanocortin 1 receptor locus. Genetics 151:1547–1557
Reilly SL, Ferrell RE, Kottke BA, Sing CF (1992) The gender-
specific apolipoprotein E genotype influence on the distri-
bution of plasma lipids and apolipoproteins in the popu-
lation of Rochester, Minnesota. II. Regression relationships
with concomitants. Am J Hum Genet 51:1311–1324
Rieder MJ, Taylor SL, Clark AG, Nickerson DA (1999) Se-
quence variation in the human angiotensin converting en-
zyme. Nat Genet 22:59–62
Roks G, Cruts M, Bullido MJ, Backhovens H, Artiga MJ,
Hofman A, Valdivieso F, Van Broeckhoven C, Van Duijn
CM (1998) The 491 A/T polymorphism in the regulatory
region of the apolipoprotein E gene and early-onset Alz-
heimer’s disease. Neurosci Lett 258:65–68
Roses AD (1996) Apolipoprotein E alleles as risk factors in
Alzheimer’s disease. Annu Rev Med 47:387–400
Rozas J, Rozas R (1999) DnaSP version 3: an integrated pro-
gram for molecular population genetics and molecular ev-
olution analysis. Bioinformatics 15:174–175
Sahota A, Yang M, Gao S, Hui SL, Baiyewu O, Gureje O,
Oluwole S, Ogunniyi A, Hall KS, Hendrie HC (1997) Apo-
lipoprotein E-associated risk for Alzheimer’s disease in the
African-American population is genotype dependent. Ann
Neurol 42:659–661
Salomaa VV, Rasi VP, Vahtera EM, Pekkanen J, Pursiainen M,
Jauhiainen M, Vartiainen E, Ehnholm CP, Myllyla G (1994)
Haemostatic factors and lipoprotein (a) in three geograph-
ical areas in Finland: the Finrisk Haemostasis Study. J Car-
diovasc Risk 1:241–248
Sayi JG, Patel NB, Premkumar DR, Adem A, Winblad B, Ma-
tuja WB, Mtui EP, et al (1997) Apolipoprotein E polymor-
phism in elderly east Africans. East Afr Med J 74:668–70
Scacchi R, Corbo RM, Rickards O, Mantuano E, Guevara A,
De Stefano GF (1997) Apolipoprotein B and E genetic poly-
morphisms in the Cayapa Indians of Ecuador. Hum Biol 69:
375–382
Seixas S, Trovoada MJ, Rocha J (1999) Haplotype analysis of
the apolipoprotein E and apolipoprotein C1 loci in Portugal
and Sao Tome e Principe (Gulf of Guinea): linkage dise-
quilibrium evidence that APOE*4 is the ancestral APOE
allele. Hum Biol 71:1001–1008
Simonsen KL, Churchill GA, Aquadro CF (1995) Properties
of statistical tests of neutrality for DNA polymorphism data.
Genetics 141:413–429
Sing CF, Davignon J (1985) Role of the apolipoprotein E poly-
morphism in determining normal plasma lipid and lipopro-
tein variation. Am J Hum Genet 37:268–285
Song Y-Q, Rogaeva E, Premkumar S, Brindle N, Kawarai T,
Orlacchio A, Yu G, Levesque G, Nishimura M, Ikeda M,
Pei Y, O’Toole C, Duara R, Barker W, Sorbi S, Freedman
M, Farrer L, St George-Hyslop P (1998) Absence of asso-
ciation between Alzheimer’s disease and the 491 regula-
tory region polymorphism of APOE. Neurosci Lett 250:
189–192
Stenga˚rd JH, Zerba KE, Pekkanen J, Ehnholm C, Nissinen A,
Sing CF (1995) Apolipoprotein E polymorphism predicts
death from coronary heart disease in a longitudinal study
of elderly Finnish men. Circulation 91:265–269
Strittmatter WJ, Saunders AM, Schmechel D, Pericak-Vance
M, Enghild J, Salvesen GS, Roses AD (1993) Apolipoprotein
E: high-avidity binding to beta-amyloid and increased fre-
quency of type 4 allele in late-onset familial Alzheimer dis-
ease. Proc Natl Acad Sci USA 90:1977–1981
Taddei K, Clarnette R, Gandy SE, Martins RN (1997) In-
creased plasma apolipoprotein E (apoE) levels in Alzheimer’s
disease. Neurosci Lett 223:29–32
Tajima F (1989) Statistical method for testing the neutral mu-
tation hypothesis by DNA polymorphisms. Genetics 123:
585–595
Talbot C, Lendon C, Craddock N, Shears S, Morris JC, Goate
A (1994) Protection against Alzheimer’s disease with apoE
epsilon 2. Lancet 343:1432–1433
Tang MX, Maestre G, Tsai WY, Liu XH, Feng L, Chung WY,
Chun M, Schofield P, Stern Y, Tycko B, Mayeux R (1996)
Relative risk of Alzheimer disease and age-at-onset distri-
butions, based on APOE genotypes among elderly African
Americans, Caucasians, and Hispanics in New York City.
Am J Hum Genet 58:574–584
Tang MX, Stern Y, Marder K, Bell K, Gurland B, Lantigua R,
Andrews H, Feng L, Tycko B, Mayeux R (1998) TheAPOE-
e4 allele and the risk of Alzheimer disease among African
Americans, whites, and Hispanics. JAMA 279:751–755
Templeton AR, Clark AG, Weiss KM, Nickerson DA, Boer-
winkle E, Sing CF (2000) Recombinational and mutational
hotspots within the human lipoprotein lipase gene. Am J
Hum Genet 66:69–83
Town T, Paris D, Fallin D, Duara R, Barker W, Gold M, Craw-
ford F, Mullan M (1998) The 491 A/T apolipoprotein E
promoter polymorphism association with Alzheimer’s dis-
ease: independent risk and linkage disequilibrium with the
known APOE polymorphism. Neurosci Lett 252:95–98
Turner ST, Weidman WH, Michels VV, Reed TJ, Ormson CL,
Fuller T, Sing CF (1989) Distribution of sodium-lithium
countertransport and blood pressure in Caucasians five to
eighty-nine years of age. Hypertension 13:378–391
Utermann G, Hees M, Steinmetz A (1977) Polymorphism of
apolipoprotein E and occurrence of dysbetalipoproteinemia
in man. Nature 269:604–607
Wall JD (1999) Recombination and the power of statistical
tests of neutrality. Genet Res 74:65–79
Watterson GA (1975) On the number of segregating sites in
genetical models without recombination. Theor Pop Biol 7:
256–276
Weir BS (1996) Genetic data analysis II. Sinauer Associates,
Sunderland, MA
Weisgraber KH (1994) Apolipoprotein E: structure-function
relationships. Adv Protein Chem 45:249–302
900 Am. J. Hum. Genet. 67:881–900, 2000
Wright S (1931) Evolution in Mendelian populations. Genetics
16:97–159
Xhignesse M, Lussier-Cacan S, Sing CF, Kessling AM, Dav-
ignon J (1991) Influences of common variants of apolipo-
protein E on measures of lipid metabolism in a sample se-
lected for health. Arterioscler Thromb 11:1100–1110
Xu Y, Berglund L, Ramakrishnan R, Mayeux R, Ngai C, Hol-
leran S, Tycko B, Leff T, Schacter N (1999) A commonHpaI
RFLP of apolipoprotein C-I increases gene transcription and
exhibits an ethnically distinct pattern of linkage disequilib-
rium with the alleles of apolipoprotein E. J Lipid Res 40:
50–58
Yamada T, Kondo A, Takamatsu J, Tateishi J, Goto I (1995)
Apolipoprotein E mRNA in the brains of patients with Alz-
heimer’s disease. J Neurol Sci 129:56–61
Zannis VI, Nicolosi RJ, Jensen E, Breslow JL, Hayes KC (1985)
Plasma and hepatic apoE isoproteins of nonhuman primates:
differences in apoE among humans, apes, and New and Old
World monkeys. J Lipid Res 26:1421–30
Zekraoui L, Lagarde JP, Raisonnier A, Gerard N, Aouizerate
A, Lucotte G (1997) High frequency of the apolipoprotein
E *4 allele in African pygmies and most of the African pop-
ulations in sub-Saharan Africa. Hum Biol 69:575–581
Zietkiewicz E, Yotova V, JarnikM, Korab-LaskowskaM, Kidd
KK, Modiano D, Scozzari R, Stoneking M, Tishkoff S,
Batzer M, Labuda D (1998) Genetic structure of the ances-
tral population of modern humans. J Mol Evol 47:146–155
